Though the possibility of super acute and acute rejection of ABO-imcompitable organ transplantation in liver is smaller than in kidney due to no blood group antigen expression on hepatocellular surface, but as a result of bile duct epithelial cells express blood group antigen, caused by the bile duct damage is relatively serious, therefore, the authors suggest that conventional plasma desensitization treatment must be done before ABOi-liver transplant. In this chapter, the indications, plasma desensitization scheme, and postoperative management of ABOi-liver are described.
This is a preview of subscription content, log in to check access.
Skogsberg U, Breimer ME, Friman S, et al. Adult abo-incompatible liver transplantation, using a and b donors. Xenotransplantation. 2006;13:154–9.CrossRefGoogle Scholar
Busquets J, Castellote J, Torras J, et al. Liver transplantation across rh blood group barriers increases the risk of biliary complications. J GastrointestSurg. 2007;11:458–63.CrossRefGoogle Scholar
Hanto DW, Fecteau AH, Alonso MH, et al. Abo-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl. 2003;9:22–30.CrossRefGoogle Scholar
Usui M, Isaji S, Mizuno S, et al. Experiences and problems pre-operative anti-cd20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for abo-incompatible living-donor liver transplantation. Clin Transplant. 2007;21:24–31.CrossRefGoogle Scholar
Lee CF, Cheng CH, Wang YC, et al. Adult living donor liver transplantation across abo-incompatibility. Medicine (Baltimore). 2015;94:e1796.CrossRefGoogle Scholar
Urbani L, Mazzoni A, De Simone P, et al. Treatment of antibody-mediated rejection with high-dose immunoglobulins in abo-incompatible liver transplant recipient. Transpl Int. 2007;20:467–70.CrossRefGoogle Scholar
Ikegami T, Taketomi A, Soejima Y, et al. Successful abo incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. Transplant Proc. 2007;39:3491–4.CrossRefGoogle Scholar
Urbani L, Mazzoni A, Bianco I, et al. The role of immunomodulation in abo-incompatible adult liver transplant recipients. J Clin Apher. 2008;23:55–62.CrossRefGoogle Scholar
Egawa H, Ohdan H, Haga H, et al. Current status of liver transplantation across abo blood-type barrier. J Hepatobiliary Pancreat Surg. 2008;15:131–8.CrossRefGoogle Scholar
Haga H, Egawa H, Shirase T, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in abo-incompatible liver transplantation. Liver Transpl. 2004;10:16–27.CrossRefGoogle Scholar
Sanchez-Urdazpal L, Batts KP, Gores GJ, et al. Increased bile duct complications in liver transplantation across the abo barrier. Ann Surg. 1993;218:152–8.CrossRefGoogle Scholar
Sato Y, Yamamoto S, Oya H, et al. Adult abo-incompatible liver transplantation by intraportal transfusion of donor-specific antigen: a case report. Transplant Proc. 2008;40:2811–4.CrossRefGoogle Scholar